Ganoderma lucidum (G. lucidum Reishi), a traditional Chinese medical fungus, has been used as a health-promoting supplement due to its anti-tumor and immuno-modulating effects. The major bioactive components in G. lucidum are reported to be polysaccharide [1] [2] [3] and gonoderic acid.
Traditionally, the fruiting body has been the only part of G. lucidum that is used for medical purposes. Recently, Sliva et al. have reported the extract of G. lucidum using boiling water suppresses the mobility of breast and prostate cancers by inhibiting nuclear factor (NF)-kB. 5, 6) As G. lucidum is available as a dietary supplement in various forms (mushroom powder, purified whole spores, broken spores, or mixtures), they compared their biological activity on cell migration and inhibition of NF-kB in human cancer cells and concluded the spores also show strong activity against human cancer cell.
6) The possible role of mushrooms to prevent cancer has been summarized in several reviews. 7, 8) Cancer inhibition by mushrooms or mushrooms polysaccharides was generally achieved through activating the immune response of the host rather than by directly inhibiting tumor cell growth. However, in medical mushroom research, polysaccharide and polysaccharide-peptides are known active anticancer compounds isolated from medicinal mushrooms such as maitake (Grifola frondosa), shiitake (Lentinula edodes), turkey tail (Coriolus versicolor) and reishi (G. lucidum). 9, 10) The polysaccharides and polysaccharide-peptides are generally thought to exert their anti-tumor effects via a systemic effect on immunity. There is an evidence that the glucanprotein complex induces biological responses by binding to membrane compartment receptor three (CR3, or CD11b/CD18) on immune effectors cells such as macrophages. 11) Furthermore, recent research has demonstrated that some of these mushroom-derived materials can produce direct cytotoxic effects on cancer cells. 12, 13) A purified fraction by HPLC from the spores of G. lucidum guided by the inhibitory activity on HL-60 cell proliferation showed biological activity contains a mixture of long chain fatty acids with molecular weights in the range of m/z 250.0 to m/z 296.4, although as yet these could not be unambiguously authenticated. Therefore, in this study, using several authentic fatty acids predicted from our analytical data, we have compared the effect of the spore extract of G. lucidum with those of several authentic fatty acids on the inhibitory activity of HL-60 cell proliferation and the production of tumor necrosis factor (TNF) production induced by lipopolysaccharide (LPS) in a mouse macrophage preparation.
MATERIALS AND METHODS
The spores (100 g) of G. lucidum, cultured at the area of Dabieshan, Anhui, China from October 2003 to July 2004 (Lot AFA), kindly supplied from Isukura Co., Ltd. (Tokyo) were dissolved in five volumes of 95% ethanol in a sealed bag, shaken gently at room temperature for 24 h and centrifuged at 10000ϫg for 20 min. The solution was evaporated to dryness on a rotary evaporator. The resulting pellet was referred as the spore extract, the yield of the spore extract from 100 g material was approximately 10% of the original weight.
Cells Human promyelocytic leukemia HL-60 cells were grown at 37°C in a humidified atmosphere containing 5% CO 2 in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) (GIBCO), penicillin (100 IU/ml, GIBCO), and streptomycin (100 mg/ml, GIBCO). Unless otherwise specified, HL-60 cells were seeded at a density of 1ϫ10 4 cells/100 ml/well and treated with 100 ml of the spore extract or various fatty acids diluted with RPMI 1640 medium. Human cancer cell line (Jurkat, MOLT4, Raji, HeLa, Caco-2, HBL-100 and OS-RC-2) were prepared from Cell Bank, Riken BioResource Center (Tsukuba, Japan). Preparation of Mouse Macrophage Cells Male C57/BL6 mice, 8-to 12-weeks-old, were purchased from Charles River Japan, Kanagawa, Japan. Briefly, mice were injected intraperitoneally (i.p.) with 2 ml of 3% thioglycolate broth. After 3 d, the peritoneal exudate cells were harvested by washing the peritoneal cavity with ice-cold PBS. The cells were seeded at 1ϫ10 6 cells/well in 24-well plates to adhere to dishes and incubated in humidified 5% CO 2 at 37°C for 1-2 h in RPMI 1640 medium supplemented with 10% FCS. Non-adherent cells were washed with PBS and the attached cells were designated as macrophages.
MTT Assay Cell proliferation was determined by the MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay. Briefly, after aspirating a medium, 187 mg/ml MTT (final concentration of 1 mg/ml) labeling solution was added to each well and the cells were further incubated for 3 h. Mitochondrial dehydrogenase activity reduced the yellow MTT dye to purple formazan, which was then solubilized by overnight incubation with MTT solubilizing reagent (10% SDS in 0.01 HCl) and absorbance was read at 595 nm on an enzyme linked immunosorbent assay (ELISA) plate reader (Bio-Tek Instruments Inc.).
Annexin-V Fluorescein Isothiocyanate/Propidium Iodide (FITC/PI) Double Stain Assay HL-60 cells were seeded at a density of 0.5ϫ10 6 cells/ml/well and treated with 500 ml of the spore extract or various fatty acids diluted with RPMI 1640 medium for the time indicated at 37°C in a humidified atmosphere containing 5% CO 2 incubator. After incubation, 1 ml of the cells suspension was transferred to a 15 ml tube and added 1 ml of cold phosphate buffered saline for washing the cells was added, and centrifuged at 500ϫg for 5 min at 4°C. Cells were re-suspended in binding buffer (HEPES buffered PBS supplemented with 2.5 mM CaCl 2 ) and 2.5 ml of FITC-labeled annexin-V and 2.5 ml of PI solution were added. Then tube was kept on ice for 10 min and then subjected on the flow cytometer (EPICS XL SYSTEM II, Beckman Coulter) which was settled on cells gated on the basis of their forward and side light scatter with any cell debris excluded from analysis. Apoptotic cells were defined as FITC ϩ /PI Ϫ cells. The gated cells were then plotted for annexin-V FITC and PI in a 2-way dot plot to assess percentage of apoptotic HL-60 cells.
TNF Assay TNF was assayed in 50 ml samples of the medium using a TNF ELISA kit (Biosource International Camarillo, CA, U.S.A.). The assay was performed according to the manufacture's instructions. Standard solutions of TNF were prepared in a RPMI 1640 medium to give the same composition as the supernatant samples.
Materials Hexadecanoic acid (16:0), heptadecanoic acid (C17:0), octadecanoic acid (18:0), nonadecanoic acid (19:0), cis-9-hexadecenoic acid (16:1), cis-10-heptadecenoic acid (C17:1), cis-9-octadecenoic acid (18:1) and cis-10-nonadecenoic acid (19:1) were purchased from Sigma-Aldrich (St.
Louis, MO, U.S.A.). Rat TNF ELISA kit was from Biosource International (Camarillo, CA, U.S.A.). All other reagents were purchased from commercial sources and were of the highest available purity.
Statistical Analysis The data are presented as the meanϮS.E.M. Statistical analyses were performed using a one-way ANOVA followed by Bonferroni's test. Significance was set at pϽ0.05.
RESULTS
The spore extract (final concentration from 100 to 300 mg extract/ml in a RPMI1640 medium containing 5% FCS) were added to Jurkat, Raji, HL-60 and MOLT4 cells for 24 h. All these blood cancer cell proliferations were significantly inhibited in a dose dependent manner in the MTT assay as shown in Fig. 1 . After the exposure of HL-60 cells to the spore extract (300 mg/ml) for 4 h, the cells were stained with annexin-V FITC/PI double-stain and analysed by flow cytometry and the FITC labeled HL-60 cells were visualized with a confocal laser scanning microscopy in Fig. 2 . The analysis suggested the spore extract could induce an early apoptosis in HL-60 cells within 4 h. However, 300 mg/ml of the spore extract did not influence a human peripheral lymphocyte in shape for 24 h (data not shown). We then examined the effects of the spore extract on human solid cancer cell lines, human HeLa (human cervical cancer cell line), Caco-2 (human colon cancer cell line), HBL-100 (human breast cancer cell line) and OS-RC-2 (human renal cancer cell line) proliferations. In this assay, we decreased the FCS concentration from 5 to 1% in a RPMI 1640 medium and increased the incubation time from 24 to 72 h for suppressing proliferation of cancer cells. Under these conditions, the proliferation of these solid cancer cells was partially inhibited as shown in Fig. 3 . The inhibitory effect of the spore extract was less potent than those of human blood cancer cells. For comparison purposes we next monitored the effect of authentic fatty acids, which are most likely contained in the spore extract, on HL-60 cell proliferation during a 24 h incubation. As shown in Fig. 4 and Table 1 , nonadecanoic acid (C19:0) shows the most potent inhibition activity for HL-60 cell proliferation with IC 50 values of 68Ϯ7 mM followed by hepta-(C17:0, 120Ϯ23 mM), octa-(C18:0, 127Ϯ4 mM) and hexadecanoic acids (C16:0, 132Ϯ25 mM), respectively. As fatty acids analysis of the mushrooms has indicated that the unsat- urated fatty acids were present at higher concentrations than saturated fatty acids, 10) we examined the effect of the corresponding C-16 to C-19 unsaturated fatty acids. Of these cis-9-hexadecenoic acid (C16:1) showed the most potent inhibitory effect on HL-60 cell proliferation, although the inhibitory activity of the four fatty acids is very similar and all are less potent than the corresponding saturated fatty acids as shown in Table 1 . Among the fatty acids examined, we have focused our attention on the anti-proliferation action of nonadecanoic acid (C19:0), which is not a novel saturated fatty acid in nature, and for comparison cis-10-nonadecenoic acid (C19:1). In order to examine the inhibitory effect on HL-60 cell proliferation in more detail, rather higher concentrations of nonadecanoic acid (C19:0) and cis-10-nonadecenoic acid (C19:1) were used. HL-60 cells were treated with 400 mM of nonadecanoic acid (C19:0) and cis-10-nonadecenoic acid (C19:1) for 12 and 24 h and assayed by annexin-V FITC/PI double staining in order to quantify the frequency of cell death by apoptosis and necrosis, respectively. Viable cells in The effect of the spore extract and fatty acids on TNF production from mouse macrophage cells induce with LPS (100 ng/ml) for 6 h after treatment in the presence or absence of the spore extract (10, 30, 100 mg/ml) or various concentrations of fatty acids (1, 5, 10 mM) for 10 min was tested. No effect was observed for the spore extract (data not shown) and saturated fatty acids, whereas rather high concentrations of unsaturated fatty acids caused inhibition of TNF secretion to varying degrees (Fig. 6) . Future studies will be needed to provide more detailed information about the effects of these fatty acids as well as the spore extract on macrophage cells. condition of cancer patients. 14) In the present study, during the bio-guided isolation of anti-tumor cell proliferation activity from ethanolic extracts of the spores of G. lucidum, physical characterization by mass spectrometry and NMR spectroscopy suggested the active substances could be a mixture of long chain fatty acids with the ranging in molecular weight from ca. 250 to 300. However, we could not identify these unambiguously due to the complexity of the mixture of long chain fatty acids. Recently, the 16-and 18-carbon fatty acids were identified as major constituents for the different gandoderma spore lipid samples by gas chromatographymass spectrometry reported by Liu et al., 15) however, they could not find a 19-carbon fatty acid. These data suggest the content of 19-carbon fatty acids in the spores of G. lucidum should be extremely small amount. Although we could not unequivocally demonstrate that the spore extract prepared by our method contains nonadecanoic acid (C19:0) and/or cis-10-nonadecenoic acid (C19:1), it is intriguing to speculate that a trace amount of both 19-carbon fatty acids should be naturally-occurring in the extract of spores of G. lucidum. Firstly because nonadecanoic acid (C19:0) is most likely to inhibit in HL-60 cells proliferation with a relative low dose compared to other similar fatty acids and secondly cis-10-nonadecenoic acid (C19:1) induces apoptosis in HL-60 cells as analyzed by annexin-V FITC/PI double stain assay. We are the first time to report both types of 19-carbon fatty acids show anti-cell proliferation activity, although there are many reports that fatty acids and unsaturated fatty acids induced apoptosis in several cell types including cancer cells. 5, 6, 16) However at present time we do not know the amounts of fatty acids in the spores of G. lucidum. Recently, nonadecanoic acid (C19:0), octadecanoic acid (C18:0), hexadecanoic (C16:0) acid were identified among the main components of the hydrophobic part of the lipopolysaccharide of the associative diazotrophic rhizobacterium Azospirillum brasilense CD. 17) Therefore it can not be ruled out that nonadecanoic acid (C19:0) (and related fatty acids such as C19:1) should occur naturally in traces amounts and coimmigrated with polysaccharides during the ethanolic extraction used in this study.
The content of fatty acids in the spores of G. lucidum is probably dependent on the soil growth conditions which would explain the variation in cell proliferation from different sources.
3) However, we can confidently conclude that the ethanolic extract of the spores of G. lucidum contain substances which inhibit tumour cell proliferation. This result is basically in agreement with the previous work of Xie et al. who extracted the polysaccharides from the fruiting body of G. lucidum (not the spores) which exhibited an inhibitory effect on tumour cell proliferation.
3) As far as we know the major bioactive components in G. lucidum are polysaccharides, ganoderic acid (triterpene), and adenosine. 3, 4) The lipid content in the spore of G. lucidumis is reported to be approximately 36%, 15) therefore it might be possible that the free fatty acids used in this study are also extracted with the hydrophilic substances such as polysaccharides. Therefore, we conclude that fatty acids including 19-carbon fatty acids in the spore of G. lucidumis could be components that contribute to its anti-tumor effects. The results from annexin-V FITC/PI double stain assay suggest the spore extract triggers tumor cell death through induction of apoptosis. The mechanism for inducing apoptosis in tumor cells is not known and needs further investigations.
On the other hand, we examined the effects of fatty acids on TNF production by LPS from mouse macrophage. The results showed monounsaturated fatty acids tended to inhibit the production of TNF, one of the proinflammatory cytokines, at rather high concentrations. Thus the present study provides scientific supporting evidence for the use of the spores extract as an anti-inflammatory agent against inflammed macrophages in vitro. To unravel potentially pharmacological actions of the spores extract, the bioactive compounds should be further characterized and their responses in animal studies monitored.
